A time-restricted feeding intervention in children and adolescents with obesity: The TRansForm study protocol

Paula Molina-Giraldo1, Serafin Murillo1, Laura Meis1

  • 1Department of Endocrinology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.

Frontiers in Nutrition
|November 17, 2022
PubMed

Insights

Time-restricted feeding (TRF) shows promise for treating childhood obesity, potentially improving metabolic health. This study evaluates TRF

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Chronobiology

Background:

  • Childhood obesity is a significant public health concern, tracking into adulthood and increasing risk for metabolic disorders.
  • Time-restricted feeding (TRF) is a potential obesity treatment strategy, but its effects in pediatric populations are unknown.
  • Understanding the impact of TRF on children's health is crucial for developing effective interventions.

Purpose of the Study:

  • To determine the short- and long-term safety and effectiveness of time-restricted feeding (TRF) in children and adolescents with obesity.
  • To investigate potential mechanisms, including circadian rhythm and gut microbiota, mediating the response to TRF.
  • To provide evidence for TRF as a viable obesity management strategy in pediatric populations.

Main Methods:

  • A randomized-controlled parallel-group clinical study involving children and adolescents (8-18 years) with obesity.
  • Participants will be assigned to either a TRF group or a control group (no time restrictions) for 2 months.
  • Measurements include anthropometric (BMI, body composition), metabolic parameters, circadian rhythm indicators, and gut microbiota analysis, with long-term follow-up.

Main Results:

  • This section is to be filled upon study completion.
  • Data analysis will focus on changes in weight, body composition, and metabolic markers.
  • Exploration of correlations between TRF, circadian rhythm, and gut microbiome shifts will be conducted.

Conclusions:

  • This study will establish the safety and efficacy of TRF for pediatric obesity.
  • Long-term effects and underlying biological mechanisms of TRF will be elucidated.
  • Findings may support the integration of TRF into clinical practice for managing childhood obesity.

Related Concept Videos

Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
155
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
327
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
581
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
226